SPRY ARS Corp: Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan
Rising demand for needle-free allergy sprays is driving the expansion of ARS Pharmaceuticals (SPRY), as confirmed by the precise GURU.Markets chart. The EV/EBITDA multiple reflects the asset's dynamics, with the indicator currently standing at 0.00. Business efficiency is bolstered by packaging robotization and AI-driven document management, while its status as an innovator in nasal therapy formulations strengthens patient trust.
Rincian metrik komprehensif lan analitis ars-pharma.com (SPRY)
- rega pasar lan target rega analis:
- data kapitalisasi saham perusahaan:
- rincian valuasi buku bisnis:
- statistik kawajiban utang lan likuiditas:
Utang marang Ekuitas ARS Pharmaceuticals|SPRY - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal ARS Pharmaceuticals, Inc.|SPRY - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku ARS Corp|SPRY - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan ARS Pharmaceuticals|Indikator likuiditas cepet ars-pharma.com
- rincian asil keuangan lan kelipatan valuasi:
SPRY - Bathi pungkasan|Bathi sing dikarepake ARS Pharmaceuticals|SPRY - Kapitalisasi marang bathi resik|Pangali Forward P/E ARS Pharmaceuticals|SPRY - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA ARS Corp|SPRY - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan ARS Pharmaceuticals|SPRY - Bathi saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan ars-pharma.com|SPRY - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep ARS Pharmaceuticals
Analisis fundamental perusahaan:SPRY (ARS Pharma)
This indicator compares the total enterprise value, including net debt, with its operating profit before taxes and depreciation, determining the real price per unit of generated cash flow. The EV/EBITDA ratio trend on the valuation chart reflects market expectations for the capitalization of ARS Pharmaceuticals (SPRY), where the exceptional patent moat of the needle-free spray may justify a high asset valuation relative to current operating income.
Pesaing wigati
Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Haleon Group HLN|Kenvue Health (KVUE) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|VRNA: Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|jyongbio.com - Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan|LGND: Pangali EV/EBITDA|Amneal Pharmaceuticals, Inc. - Nilai bisnis marang bathi operasional sadurunge panyusutan|PRGO (Perrigo Company) - Pangali EV/EBITDA|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Alvotech Biopharmaceuticals ALVO|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Liquidia Corporation (LQDA)|GLPG (glpg.com) - Nilai bisnis marang bathi operasional sadurunge panyusutan|Pangali EV/EBITDA ANIP (ANI Pharmaceuticals, Inc.)|Pangali EV/EBITDA MannKind Corp MNKD|AMPH - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai bisnis marang bathi operasional sadurunge panyusutan PCRX (Pacira Corp)|Theravance Biopharma (TBPH) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|AQST - Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan SCPH|TECX: Nilai bisnis marang bathi operasional sadurunge panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Tonix Pharmaceuticals Inc. (TNXP)|SXTC: Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan|Pangali EV/EBITDA EPRX (Eupraxia Pharmaceuticals Inc.)|Nilai bisnis marang bathi operasional sadurunge panyusutan BHST|eXoZymes - Pangali EV/EBITDA|ORMP - Pangali EV/EBITDA|enterabio.com (ENTX) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|MindWalk Therapeutics - Nilai bisnis marang bathi operasional sadurunge panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ABVC BioPharma|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan cumberlandpharma.com (CPIX)|Pangali EV/EBITDA QNTM|Pangali EV/EBITDA FibroGen Inc (FGEN)|Pangali EV/EBITDA TELO (Telomir Pharma)|RANI - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Synergy CHC Corporation - Pangali EV/EBITDA|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Rallybio Corporation|LEXX (lexariabioscience.com) - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Pulmatrix Inc (PULM) - Pangali EV/EBITDA|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan PTHL|APM (Aptorum) - Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan|Pangali EV/EBITDA LYRA|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan impactbiomedinc.com|Pangali EV/EBITDA TNFA (TNF Pharmaceuticals, Inc.)|YCBD - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|PainReform Limited - Pangali EV/EBITDA|CYTO - Pangali EV/EBITDA|Lipella Pharmaceuticals (LIPO) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|OPTN (optinose.com) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Pieris Pharmaceuticals, Inc.|Procaps Group (PROC) - Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Petros (PTPI)|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Qilian International Corp|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Acelyrin, Inc. SLRN|TFFP (tffpharma.com) - Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan
